Autophagy in skeletal muscle: implications for Pompe disease
- PMID: 20040311
- PMCID: PMC2948975
- DOI: 10.5414/cpp47042
Autophagy in skeletal muscle: implications for Pompe disease
Abstract
Pompe disease is caused by an inherited deficiency of acid a-glucosidase (GAA), a lysosomal enzyme that catalyzes the breakdown of glycogen to glucose. In the absence of GAA, enlarged, glycogen-laden lysosomes accumulate in multiple tissues, although the major clinical manifestations are seen in cardiac and skeletal muscle. For many years, it was believed that the rupture of glycogen-filled lysosomes was the major cause of the profound muscle damage observed in patients with Pompe disease. Here, we present evidence that a failure of productive autophagy in muscle tissue contributes strongly to disease pathology in both patients with Pompe disease and GAA-knockout mice. In the GAA-knockout mouse model, progressive accumulation of autophagic vesicles is restricted to Type II-rich muscle fibers. Not only does this build-up of autophagosomes disrupt the contractile apparatus in the muscle fibers, it also interferes with enzyme replacement therapy by acting as a sink for the recombinant enzyme and preventing its efficient delivery to the lysosomes. Our data indicate that a re-examination of the presumed pathological mechanism in Pompe disease is necessary, and suggest that successful treatment of patients with Pompe disease will require consideration of the dramatic failure of autophagy that occurs in this disease.
Figures




Similar articles
-
When more is less: excess and deficiency of autophagy coexist in skeletal muscle in Pompe disease.Autophagy. 2009 Jan;5(1):111-3. doi: 10.4161/auto.5.1.7293. Epub 2009 Jan 30. Autophagy. 2009. PMID: 19001870 Free PMC article.
-
Autophagy and lysosomes in Pompe disease.Autophagy. 2006 Oct-Dec;2(4):318-20. doi: 10.4161/auto.2984. Epub 2006 Oct 5. Autophagy. 2006. PMID: 16874053
-
Murine muscle cell models for Pompe disease and their use in studying therapeutic approaches.Mol Genet Metab. 2009 Apr;96(4):208-17. doi: 10.1016/j.ymgme.2008.12.012. Epub 2009 Jan 22. Mol Genet Metab. 2009. PMID: 19167256 Free PMC article.
-
Gene Therapy for Pompe Disease: The Time is now.Hum Gene Ther. 2019 Oct;30(10):1245-1262. doi: 10.1089/hum.2019.109. Epub 2019 Sep 9. Hum Gene Ther. 2019. PMID: 31298581 Review.
-
Autophagy and mitochondria in Pompe disease: nothing is so new as what has long been forgotten.Am J Med Genet C Semin Med Genet. 2012 Feb 15;160C(1):13-21. doi: 10.1002/ajmg.c.31317. Epub 2012 Jan 17. Am J Med Genet C Semin Med Genet. 2012. PMID: 22253254 Free PMC article. Review.
Cited by
-
Satellite cells fail to contribute to muscle repair but are functional in Pompe disease (glycogenosis type II).Acta Neuropathol Commun. 2018 Oct 31;6(1):116. doi: 10.1186/s40478-018-0609-y. Acta Neuropathol Commun. 2018. PMID: 30382921 Free PMC article.
-
Therapeutic Approaches in Lysosomal Storage Diseases.Biomolecules. 2021 Nov 26;11(12):1775. doi: 10.3390/biom11121775. Biomolecules. 2021. PMID: 34944420 Free PMC article. Review.
-
Correction of oxidative stress enhances enzyme replacement therapy in Pompe disease.EMBO Mol Med. 2021 Nov 8;13(11):e14434. doi: 10.15252/emmm.202114434. Epub 2021 Oct 4. EMBO Mol Med. 2021. PMID: 34606154 Free PMC article.
-
Novel degenerative and developmental defects in a zebrafish model of mucolipidosis type IV.Hum Mol Genet. 2017 Jul 15;26(14):2701-2718. doi: 10.1093/hmg/ddx158. Hum Mol Genet. 2017. PMID: 28449103 Free PMC article.
-
Pros and cons of different ways to address dysfunctional autophagy in Pompe disease.Ann Transl Med. 2019 Jul;7(13):279. doi: 10.21037/atm.2019.03.51. Ann Transl Med. 2019. PMID: 31392191 Free PMC article. Review.
References
-
- Amalfitano A, Bengur AR, Morse RP, Majure JM, Case LE, Veerling DL, et al. Recombinant human acid α-glucosidase enzyme therapy for infantile glycogen storage disease Type II: results of a Phase I/II clinical trial. Genet Med. 2001;3:132–138. - PubMed
-
- Berg TO, Fengsrud M, Stromhaug PE, Berg T, Seglen PO. Isolation and characterization of rat liver amphisomes. Evidence for fusion of autophagosomes with both early and late endosomes. J Biol Chem. 1998;273:21883–21892. - PubMed
-
- Fukuda T, Ewan L, Bauer M, Mattaliano RJ, Zaal K, Ralston E, et al. Dysfunction of endocytic and autophagic pathways in a lysosomal storage disease. Ann Neurol. 2006b;59:700–708. - PubMed
-
- Fukuda T, Roberts A, Ahearn M, Zaal K, Ralston E, Plotz PH, et al. Autophagy and lysosomes in Pompe disease. Autophagy. 2006c;2:318–320. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous